Sign up to save your podcasts
Or
Share Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Concerning Kinases: Therapeutic Considerations for RET Rearranged NSCLC
Guest: D. Ross Camidge, MD, PhD
With only two targeted therapy options available for RET rearranged advanced non-small cell lung cancer, how do we select the best approach? Dr. Ross Camidge, the Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado, discusses treatment options for NSCLC.
View all episodes
By ReachMDGuest: D. Ross Camidge, MD, PhD
With only two targeted therapy options available for RET rearranged advanced non-small cell lung cancer, how do we select the best approach? Dr. Ross Camidge, the Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado, discusses treatment options for NSCLC.